Specifications
- Purity
- ≥97% (HPLC)
- Appearance
- White to off-white solid
- Identity
- 1H-NMR
Properties
- Solvents
- chloroform
Documentation
- Safety Data Sheet (SDS)
- CDX D0390 MSDS.pdf
Category: API's & Intermediates
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
Major naproxen demethylation metabolite. Naproxen demethylation is mediated primarily by CYP2C9. Can be used for assaying naproxen metabolites.
Synonyms | (S)-6-Hydroxy-α-methyl-2-naphthaleneacetic acid, (S)-6-O-Desmethylnaproxen |
---|---|
Purity | ≥97% (HPLC) |
Appearance | White to off-white solid |
CAS-Number | 52079-10-4 |
Molecular Formula | C13H12O3 |
Molecular Weight | 216.2 |
Identity | 1H-NMR |
Solvents | chloroform |
Smiles | C[C@H](C(O)=O)C1=CC2=CC=C(O)C=C2C=C1 |
InChi Key | XWJUDDGELKXYNO-QMMMGPOBSA-N |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice | Protect from light and moisture. |
Use / Stability | Stable for at least 2 years after receipt when stored at -20°C. |
Hazard statements | H302-H317-H400 |
Precautionary statements | P273-P280 |
GHS Symbol | GHS07+GHS09 |
Signal word | Warning |
RIDADR | UN3077 9 |
Transportation | Excepted Quantities |
References | (1) C.H. Kiang, et al.: Drug Metab. Dispos. 17, 43 (1989), (2) A. Rettie, et al.: Chem. Res. Toxicol. 5, 54 (1992), (3) T.B. Vree, et al.: Br. J. Clin. Pharmacol. 35, 467 (1993), (4) T.B. Vree, et al.: Biopharm. Drug Dispos. 14, 491 (1993), (5) P. Bonnabry, et al.: Eur. J. Clin. Pharmacol. 49, 305 (1996), (6) J.O. Miners, et al.: Biochem. Pharmacol. 51, 1003 (1996), (7) T.S. Tracy, et al.: Eur. J. Clin. Pharmacol. 52, 293 (1997), (8) S. Rao, et al.: J. Med. Chem. 43, 2789 (2000), (9) L. Wei, et al.: Mol. Pharmacol. 72, 1280 (2007), (10) K.C. Duggan, et al.: J. Biol. Chem. 285, 34950 (2010) |
InChi | InChI=1S/C13H12O3/c1-8(13(15)16)9-2-3-11-7-12(14)5-4-10(11)6-9/h2-8,14H,1H3,(H,15,16)/t8-/m0/s1 |
Quantity | 10 mg, 50 mg, Bulk |